22 related articles for article (PubMed ID: 18566996)
1. Retraction Note: Non-thermal plasma inhibits human cervical cancer HeLa cells invasiveness by suppressing the MAPK pathway and decreasing matrix metalloproteinase-9 expression.
Li W; Yu KN; Bao L; Shen J; Cheng C; Han W
Sci Rep; 2024 Jun; 14(1):12785. PubMed ID: 38834769
[No Abstract] [Full Text] [Related]
2. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Lian Y; Zeng S; Wen S; Zhao X; Fang C; Zeng N
Technol Cancer Res Treat; 2023; 22():15330338231189399. PubMed ID: 37525872
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.
Song L; Fan Z; Jun N; Benjia L; Zequn L; Xilong W; Zhongming J; Yong H; Xiaohong W; Kai C; Zhenlin Y
Oncotarget; 2016 Dec; 7(51):85163-85175. PubMed ID: 27835891
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.
Zhuang Z; Zhou R; Xu X; Tian T; Liu Y; Liu Y; Lian P; Wang J; Xu K
Med Oncol; 2013; 30(3):580. PubMed ID: 23673986
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.
Zhang Y; Wei L; Yu J; Li G; Zhang X; Wang A; He Y; Li H; Yin D
Oncol Rep; 2014 Nov; 32(5):1787-95. PubMed ID: 25176506
[TBL] [Abstract][Full Text] [Related]
6. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
Ahmed N; Pansino F; Baker M; Rice G; Quinn M
J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.
Wu XL; Lin KJ; Bai AP; Wang WX; Meng XK; Su XL; Hou MX; Dong PD; Zhang JJ; Wang ZY; Shi L
World J Gastroenterol; 2014 Aug; 20(30):10440-8. PubMed ID: 25132760
[TBL] [Abstract][Full Text] [Related]
9. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
10. Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway.
Wang J; Zhang Z; Xu K; Sun X; Yang G; Niu W; Liu E; Peng C; Lin P; Wang J; Chen R; Agrez M; Niu J
Int J Cancer; 2008 Sep; 123(6):1311-7. PubMed ID: 18566996
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
12. Thymosin beta4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80.
Cierniewski CS; Papiewska-Pajak I; Malinowski M; Sacewicz-Hofman I; Wiktorska M; Kryczka J; Wysocki T; Niewiarowska J; Bednarek R
Ann N Y Acad Sci; 2010 Apr; 1194():60-71. PubMed ID: 20536451
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]